Sandbox/Qx: Difference between revisions
< Sandbox
Created page with "{| {{table}} | align="center" style="background:#f0f0f0;"|'''FIRST-LINE COMBINATION CHEMOTHERAPY REGIMENS''' | align="center" style="background:#f0f0f0;"|'''SECOND-LINE CHEMOT..." |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Thymoma}} | |||
{| {{table}} | {| {{table}} | ||
| align="center" style="background:#f0f0f0;"|'''FIRST-LINE COMBINATION CHEMOTHERAPY REGIMENS''' | | align="center" style="background:#f0f0f0;" colspan=2|'''FIRST-LINE COMBINATION CHEMOTHERAPY REGIMENS''' | ||
| align="center" style="background:#f0f0f0;"|'''SECOND-LINE CHEMOTHERAPY''' | | align="center" style="background:#f0f0f0;"|'''SECOND-LINE CHEMOTHERAPY''' | ||
|- | |- | ||
| CAP (preferred for thymoma) <BR> * Cisplatin 50 mg/m² IV day 1 <BR> * Doxorubicin 50 mg/m² IV day 1 <BR> * Cyclophosphamide 500 mg/m² IV day 1 <BR> Administered every 3 weeks||Etoposide <BR> Ifosfamide <BR> Pemetrexed <BR> Octreotide (including LAR) + prednisone <BR> 5-FU and leucovirin <BR> Gemcitabine <BR> Paclitaxel | | '''CAP''' (preferred for thymoma) <BR> * Cisplatin 50 mg/m² IV day 1 <BR> * Doxorubicin 50 mg/m² IV day 1 <BR> * Cyclophosphamide 500 mg/m² IV day 1 <BR> Administered every 3 weeks|| '''PE''' <BR> * Cisplatin 60 mg/m² IV day 1 <BR> *Etoposide 120 mg/m²/d IV days 1 -3 <BR> Administered every 3 weeks||rowspan=3 valign=top|Etoposide <BR> Ifosfamide <BR> Pemetrexed <BR> Octreotide (including LAR) + prednisone <BR> 5-FU and leucovirin <BR> Gemcitabine <BR> Paclitaxel | ||
|- | |- | ||
| CAP with Prednisone <BR> * Cisplatin 30 mg/m² IV days 1-3 <BR> * Doxorubicin 20 mg/m²/d <BR> IV continuous infusion on days 1 to 3 <BR> * Cyclophosphamide 500 mg/m² IV on day 1 <BR> * Prednisone 100 mg/day on days 1-5 <BR> Administered every 3 weeks|| | | '''CAP with Prednisone''' <BR> * Cisplatin 30 mg/m² IV days 1-3 <BR> * Doxorubicin 20 mg/m²/d <BR> IV continuous infusion on days 1 to 3 <BR> * Cyclophosphamide 500 mg/m² IV on day 1 <BR> * Prednisone 100 mg/day on days 1-5 <BR> Administered every 3 weeks||'''VIP''' <BR> * Etoposide 75 mg/m² on days 1-4 <BR>* Ifosfamide 1.2 g/m² on days 1-4 <BR> * Cisplatin 20 mg/m² on days 1-4 <BR> Administered every 3 weeks | ||
|- | |- | ||
| ADOC <BR> * Cisplatin 50 mg/m² IV day 1 <BR> * Doxorubicin 40 mg/m² IV day 1 <BR> * Vincristine 0.6 mg/m² IV day 3 <BR> * Cyclophosphamide 700 mg/m² IV day 4 <BR> Administered every 3 weeks || | | '''ADOC''' <BR> * Cisplatin 50 mg/m² IV day 1 <BR> * Doxorubicin 40 mg/m² IV day 1 <BR> * Vincristine 0.6 mg/m² IV day 3 <BR> * Cyclophosphamide 700 mg/m² IV day 4 <BR> Administered every 3 weeks || '''Carboplatin/Paclitaxel''' (preferred for Thymic Carcinoma) <BR>* Carboplatin AUC 6 <BR> * Paclitaxel 225 mg/m² <BR> Administered every 3 weeks | ||
|- | |- | ||
|} | |} | ||
Latest revision as of 20:54, 27 February 2014
|
Thymoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Sandbox/Qx On the Web |
|
American Roentgen Ray Society Images of Sandbox/Qx |
| FIRST-LINE COMBINATION CHEMOTHERAPY REGIMENS | SECOND-LINE CHEMOTHERAPY | |
| CAP (preferred for thymoma) * Cisplatin 50 mg/m² IV day 1 * Doxorubicin 50 mg/m² IV day 1 * Cyclophosphamide 500 mg/m² IV day 1 Administered every 3 weeks |
PE * Cisplatin 60 mg/m² IV day 1 *Etoposide 120 mg/m²/d IV days 1 -3 Administered every 3 weeks |
Etoposide Ifosfamide Pemetrexed Octreotide (including LAR) + prednisone 5-FU and leucovirin Gemcitabine Paclitaxel |
| CAP with Prednisone * Cisplatin 30 mg/m² IV days 1-3 * Doxorubicin 20 mg/m²/d IV continuous infusion on days 1 to 3 * Cyclophosphamide 500 mg/m² IV on day 1 * Prednisone 100 mg/day on days 1-5 Administered every 3 weeks |
VIP * Etoposide 75 mg/m² on days 1-4 * Ifosfamide 1.2 g/m² on days 1-4 * Cisplatin 20 mg/m² on days 1-4 Administered every 3 weeks | |
| ADOC * Cisplatin 50 mg/m² IV day 1 * Doxorubicin 40 mg/m² IV day 1 * Vincristine 0.6 mg/m² IV day 3 * Cyclophosphamide 700 mg/m² IV day 4 Administered every 3 weeks |
Carboplatin/Paclitaxel (preferred for Thymic Carcinoma) * Carboplatin AUC 6 * Paclitaxel 225 mg/m² Administered every 3 weeks | |